Key growth drivers in the genome editing market include rising cancer/genetic disorder cases, increased investments, and supportive policies. North America leads in R&D, while Asia Pacific shows rapid ...

A genome-editing technique known as prime editing holds potential for treating many diseases by transforming faulty genes ...

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived toolbox. Metagenomi is ...

Genome editing is a powerful biotechnology tool that allows scientists to make precise changes to an organism's DNA. It involves the use of specialized enzymes, known as engineered nucleases or ...

Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection ...

In a major step toward treating rare neurological diseases, scientists have used gene editing to correct mutations inside the ...

Traditional genome editing faced limitations in achieving ultimate precision until now. Prof. Buchholz's team has broken through this barrier by creating what many have sought after: a zinc-finger ...

Feng Zhang is a core institute member of the Broad Institute of MIT and Harvard, as well as an investigator at the McGovern Institute for Brain Research at MIT, co-director of the K. Lisa Yang and ...

Delivering genome editing machinery into plant cells remains a challenge despite the dire need for high yield crops with enhanced nutritional value that are resistant to disease and resilient in the ...